Place an order request to the broker. The personal manager will contact you to confirm the order.

Order Summary

Asset: Select instrument
Quantity: -
Price per Unit: ? This price is indicative and shown for informational purposes only. The final execution price may change. -
Total Amount: -

Order Expiration

Order remains active until you cancel it or it gets filled

Order expires at the end of the selected day

Order Placed Successfully

Your order has been submitted! Our team will contact you shortly to confirm.

Order Type: -
Asset: -
Quantity: -
Total Amount: -
Manually record a past trade to keep your portfolio up to date. This helps track your P&L accurately.
Total Amount: $0.00

Trade Added Successfully

Trade recorded! Your portfolio data will be recalculated.

Type: -
Asset: -
Quantity: -
Price: -
Total: -

Chat Options

Web Search
Search the internet for recent information
Portfolio Context
Include your portfolio in the conversation
Market Data
Access real-time market information
Watchlist Context
Include your watchlist companies

Investment Managers Series Trus (IREX)

2026-10-13T19:34:06.732514+00:00

Key Updates

IREX rebounded +10.51% since the last report, rising from $8.54 to $9.44, partially retracing the sharp -17.55% decline documented in the prior report. Despite this bounce, the position within a one-day window remains essentially flat (-0.32%), while the 5-day (-30.02%) and 1-month (-39.99%) windows confirm the stock remains deep in a multi-week collapse. No company-specific news was identified for IREX during this period; the rebound appears price-driven rather than catalyst-driven, consistent with the extreme intraday and week-over-week volatility that has characterized this security since early October (reports of -3.19%, +6.80%, -17.55%, and now +10.51% in successive updates).

Current Trend

The YTD performance of -68.91% and 6-month decline of -64.95% confirm a dominant and severe downtrend that has not been reversed by the current bounce. The whipsaw pattern over the past week — a swing from ~$9.70 to $10.36, down to $8.54, and now back to $9.44 — indicates a market structure consistent with a high-beta or leveraged product experiencing extreme volatility decay rather than a fundamentally-driven recovery. Near-term support is observed around the $8.54 level (last report's low), while resistance sits near $10.36, the recent local high from October 12.

Investment Thesis

IREX's price behavior — large daily swings, structural erosion of value over time despite periodic rallies, and the magnitude of YTD losses — is consistent with products subject to daily-reset leverage mechanics, as described in the broader market news on comparable leveraged/inverse ETF launches and liquidations. Under this structure, returns over periods longer than a single day diverge materially from the stated leverage target due to compounding in volatile markets, a dynamic explicitly cited by issuers of similar products (Yorkville America, Tradr).

Thesis Status

The thesis remains intact and is reinforced by the latest price action. The sharp -17.55% drop followed by a +10.51% rebound exemplifies the compounding/volatility-decay risk inherent to leveraged structures, rather than signaling a sustainable trend reversal. The sequence of sharp, directionless swings without any underlying news catalyst is consistent with continued value erosion typical of high-leverage, daily-reset products, as seen in the severe YTD and 6-month losses.

Key Drivers

No IREX-specific news was published during this period. However, sector-wide developments provide important context for the risk profile of comparable leveraged products:

  • Tradr Capital announced the liquidation of five leveraged/inverse ETFs (CPNX, NXPX, PONX, SMZ, TSEU), underscoring the short operational lifecycle and elevated closure risk common to this product category (PR Newswire)
  • Yorkville America launched new 2x leveraged and inverse daily-target ETFs (MNGZ, MNGB), explicitly warning that investors "could lose all or substantially all of their value in a single day," and that the funds are unsuitable for passive, buy-and-hold investors (PR Newswire, PR Newswire)
  • Jane Street's entry into the leveraged ETF swaps market ($1.2bn notional in Q2) signals increasing institutional/dealer participation and liquidity infrastructure supporting this fast-growing but niche derivatives segment (Bloomberg)

Technical Analysis

IREX is showing a highly volatile, range-bound pattern between approximately $8.54 (support) and $10.36 (resistance) over the past week, with no clear directional break. The current price of $9.44 sits mid-range between these two levels. The negligible 1-day change (-0.32%) despite the sizable reported rebound since the last report suggests the +10.51% move occurred predominantly in the days immediately following the prior report rather than in the most recent session. The steep YTD downtrend (-68.91%) remains the dominant technical feature, with short-term rallies occurring within an overall declining channel.

Bull Case

  • Increasing institutional dealer participation, exemplified by Jane Street's entry into leveraged ETF swaps, signals growing liquidity infrastructure that could support more efficient trading and tighter spreads for leveraged products like IREX (Bloomberg)
  • Continued new product launches by issuers such as Yorkville America indicate sustained investor demand for leveraged thematic exposure, suggesting the broader leveraged ETF niche remains commercially viable despite volatility (PR Newswire)
  • The sharp +10.51% rebound since the last report demonstrates the capacity for rapid short-term price recovery, which may offer tactical trading opportunities for sophisticated, actively-monitoring investors
  • Growing dealer competition in the swaps market for risky ETFs could reduce counterparty concentration risk and improve hedging capacity across the leveraged ETF ecosystem, indirectly benefiting products like IREX (Bloomberg)
  • The expansion of the leveraged/inverse ETF market (new launches such as MNGZ/MNGB) reflects continued structural growth of the category in which IREX operates, which could support longer-term sector relevance (PR Newswire)

Bear Case

  • Tradr's liquidation of five comparable leveraged/inverse ETFs highlights the elevated closure risk and short operational lifecycle typical of this product category, a direct structural risk factor for IREX (PR Newswire)
  • Issuers of comparable leveraged products explicitly warn that investors "could lose all or substantially all of their value in a single day," directly describing the risk profile consistent with IREX's historical price action (PR Newswire)
  • Daily-reset leverage mechanics and compounding effects in volatile markets cause long-term returns to diverge significantly from target exposure, consistent with IREX's -68.91% YTD decline despite periodic sharp rallies (PR Newswire)
  • These leveraged products are explicitly designed for sophisticated, short-term traders rather than long-term holders, making them structurally unsuitable for buy-and-hold positioning and elevating downside risk over extended holding periods (PR Newswire)
  • Severe realized volatility across multiple timeframes (-30.02% 5d, -39.99% 1m, -64.95% 6m) reflects ongoing value destruction typical of leveraged ETF decay, with no identified company-specific catalyst to reverse the trend
CapPilot is AI-powered and can make mistakes. Please double-check responses.

CapPilot leverages generative AI to distill market insights and analysis, as well as answer your questions in chat. While we work hard to ensure accuracy, AI-generated content may occasionally contain inaccuracies or outdated information.

We value your feedback — reporting errors helps us continuously improve.